Patents by Inventor William F. Lathrop

William F. Lathrop has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COSMETIC SKIN CARE COMPOSITION
    Publication number: 20240173231
    Abstract: A topical composition comprising: (a) a cosmetic skin benefit agent; (b) a retinoid; and (c) a dermatologically acceptable vehicle. The compositions are useful as cosmetic anti-ageing skin care creams and lotions.
    Type: Application
    Filed: March 10, 2022
    Publication date: May 30, 2024
    Applicant: Conopco, Inc., d/b/a UNILEVER
    Inventors: Van AU, Andrew John DAVIS, Marian Pereira GUELAKIS, Bijan HARICHIAN, William F. LATHROP, Jianming LEE, Nandou LU, Jose Guillermo ROSA
  • PROLIPID COMPOSITION FOR PERSONALIZED BENEFITS AND METHOD FOR USING THE SAME
    Publication number: 20240050342
    Abstract: The present invention is directed to a prolipid composition that penetrates the stratum corneum. More particularly, the invention is directed to a prolipid composition that provides personalized benefits by rapidly restoring the skins natural lipid balance. Such a composition results in elongated fatty acid and/or lipid production deep in the stratum corneum and near the surface of the stratum lucidum. The composition at least comprises a fatty acid, fatty ester and/or an acylglycerol and an activator of a peroxisome proliferator-activated receptor.
    Type: Application
    Filed: December 21, 2021
    Publication date: February 15, 2024
    Applicant: Conopco, Inc., d/b/a UNILEVER
    Inventors: John Steven BAJOR, Brian John DOBKOWSKI, Galina YAROVA, William F. LATHROP, Jason Peter HARCUP
  • Substituted 2-arylimino heterocycles and compositions containing them for use as progesterone receptor binding agents
    Publication number: 20030207865
    Abstract: This invention relates to 2-arylimino heterocycles, including 2-arylimino-1,3-thiazolidines, 2-arylimino-2,3,4,5-tetrahydro-1,3-thiazines, 2-arylimino-1,3-thiazolidin-4-ones, 2-arylimino-1,3-thiazolidin-5-ones, and 2-arylimino-1,3-oxazolidines, and their use in modulating progesterone receptor mediated processes, and pharmaceutical compositions for use in such therapies.
    Type: Application
    Filed: October 23, 2001
    Publication date: November 6, 2003
    Inventors: Brian R. Dixon, Cedo M. Bagi, Catherine R. Brennan, David R. Brittelli, William H. Bullock, Jinshan Chen, William L. Collibee, Robert Dally, Jeffrey S. Johnson, Harold C. E. Kluender, William F. Lathrop, Peiying Liu, Carol Ann Mase, Aniko M. Redman, William J. Scott, Klaus Urbahns, Donald J. Wolanin
  • Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
    Patent number: 6353006
    Abstract: This invention relates to 2-arylimino heterocycles, including 2-arylimino-1,3-thiazolidines, 2-arylimino-2,3,4,5-tetrahydro-1,3-thiazines, 2-arylimino-1,3-thiazolidin-4-ones, 2-arylimino-1,3-thiazolidin-5-ones, and 2-arylimino-1,3-oxazolidines, and their use in modulating progesterone receptor mediated processes, and pharmaceutical compositions for use in such therapies.
    Type: Grant
    Filed: December 3, 1999
    Date of Patent: March 5, 2002
    Assignee: Bayer Corporation
    Inventors: Brian R. Dixon, Cedo M. Bagi, Catherine R. Brennan, David R. Brittelli, William H. Bullock, Jinshan Chen, William L. Collibee, Robert Dally, Jeffrey S. Johnson, Harold C. E. Kluender, William F. Lathrop, Peiying Liu, Carol Ann Mase, Anikó M. Redman, William J. Scott, Klaus Urbahns, Donald J. Wolanin